Filing Flows › Comparisons › DBVT vs OTLK
DBV Technologies S.A. vs Outlook Therapeutics: DBVT and OTLK compared
DBV Technologies S.A. is the larger company: $1.6M of revenue in its latest quarter (Q3 2026) against $1.5M for Outlook Therapeutics (Q3 FY25).
Where the money goes: DBVT and OTLK
DBV Technologies S.A. (DBVT) · Q3 2026
DBV Technologies S.A., Q3 2026: revenue $1.6M (-43% year over year), net loss $64.5M, operating cash flow −$51.5M. The chart follows the revenue to costs, profit and cash.
Outlook Therapeutics (OTLK) · Q3 FY25
Outlook Therapeutics, Q3 FY25: revenue $1.5M, net loss $20.2M, operating cash flow −$11.9M. The chart follows the revenue to costs, profit and cash.
| DBV Technologies S.A. (DBVT) | Outlook Therapeutics (OTLK) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 FY25 |
| Revenue | $1.6M | $1.5M |
| Revenue growth, Y/Y | -43% | — |
| Operating margin | n/m | n/m |
| Net earnings | −$64.5M | −$20.2M |
| Operating cash flow | −$51.5M | −$11.9M |
Questions
Which is bigger, DBV Technologies S.A. or Outlook Therapeutics?
DBV Technologies S.A. is the larger company: $1.6M of revenue in its latest quarter (Q3 2026) against $1.5M for Outlook Therapeutics (Q3 FY25).
More: DBV Technologies S.A. earnings · how DBV Technologies S.A. makes money · Outlook Therapeutics earnings · how Outlook Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 28, 2026; 10-Q filed Aug 14, 2025). Fiscal quarters can end on different dates. Not investment advice.